Introduction
============

Plants produce an array of diverse secondary metabolites that have antimicrobial activities including preformed, so‐called phytanticipants and phytoalexins, which are synthesized in response to pathogen attack. For this purpose, flavonoids, isoprenoids and alkaloids comprise three major classes of secondary metabolites synthesized by higher plants. These compounds are essential for diverse plant defence mechanisms and are furthermore implicated in a broad range of physiological processes ([@b41]; [@b23]).

Evolutionary successful pathogens are able to circumvent the toxic effect of antimicrobial compounds by enzymatic inactivation, alteration of the cellular target, reduced uptake of the toxic compounds, or active efflux ([@b63]; [@b60]). In this context, multidrug efflux (MDE) has been suggested for a broad range of structurally unrelated compounds. So far, most emphasis has been devoted to the investigation of MDE phenomena in human pathogens. However, genome analyses of various microorganisms revealed the ubiquitous occurrence of genes encoding MDE pumps ([@b43]). Five well‐characterized families of MDE pump exist: the ATP‐binding cassette (ABC) family, the major facilitator superfamily (MFS), the resistance‐nodulation‐cell division (RND) superfamily, the small multidrug resistance (SMR) family, and the multidrug and toxic compound extrusion (MATE) family ([@b11]). Efflux by proteins of the MFS, RND, SMR and MATE families is driven by proton (and sodium) motive force while ATP hydrolysis drives efflux in ABC transporters ([@b37]; [@b48]; [@b46]; [@b2]). In Gram‐negative bacteria, RND‐type transporters reside in the inner membrane and function in concert with two types of proteins: the accessory membrane fusion proteins, which are located in the periplasmic space, and outer membrane protein channels ([@b46]; [@b2]). These tripartite transport systems enable drug efflux across both membranes ([@b65]).

For plant pathogens, protection against toxic compounds by MDE transporters has particularly been studied in fungal organisms. Mutation of genes encoding ABC transporters of *Gibberella pulicaris* and *Botrytis cinerea* resulted in decreased tolerance to phytoalexins and thus led to impaired virulence ([@b15]; [@b53]; [@b17]). In phytopathogenic and other plant‐associated bacteria so far only few MDE pumps belonging to the RND superfamily have been associated with respective interactions, for example in *Agrobacterium tumefaciens* ([@b42]; [@b44]), in the nitrogen‐fixing symbiont, *Rhizobium etli* ([@b20]), in *Pseudomonas syringae* ([@b56]), in *Erwinia chrysanthemi* ([@b33]) and in *Bradyrhizobium japonicum* ([@b29]).

One of the economically most important bacterioses represents fire blight on rosaceous plants, which is particularly destructive to apple and pear trees ([@b16]). The causal agent of this disease is *Erwinia amylovora*, a member of the *Enterobacteriaceae*. The initial symptom of fire blight is water soaking followed by wilting and rapid necrosis leaving infected tissue with a scorched, blackened appearance. The spread of the pathogen through the host tissue and xylem into all parts of a plant can lead to loss of entire trees ([@b62]). The commercial implications of fire blight outbreaks are aggravated by the limited effectiveness of current control strategies ([@b49]). Thus, a better understanding of the molecular interactions between plant and pathogen can lead to improved design of antibacterial compounds and genetically engineered plants.

In *E. amylovora*, two essential pathogenicity factors have been identified: the *hrp/dsp* genes encoding a type III protein secretion system and disease‐specific effector proteins ([@b55]; [@b5]; [@b61]) and the extracellular polysaccharide amylovoran ([@b9]). Further studies revealed a number of additional factors that are not directly involved in the induction of disease symptoms but allow the pathogen to survive *in planta* ([@b36]; [@b1]; [@b10]).

A resistance mechanism to bypass the antimicrobial effects of secondary metabolites of the host defence has been studied for *E. amylovora* by [@b13]). It was shown that the *E. amylovora* RND‐family efflux pump AcrAB was essential for resistance against plant‐derived antimicrobial toxins, particularly against the apple phytoalexin, phloretin, and for a successful colonization of plant tissue. Based on that finding, our present study focused on the involvement of the outer membrane protein, TolC, in MDE, its specific interaction with AcrAB, and its involvement in virulence and *in planta* survival of *E. amylovora*. TolC homologues have been shown to be involved in resistance against antimicrobial compounds in mammalian pathogens such as *Escherichia coli* ([@b19]; [@b54]; [@b8]), *Salmonella enterica* ([@b6; @b7]) and *Borrelia bugdorferi* ([@b12]). Furthermore, TolC has been studied to variable extent in the nitrogen‐fixing organism, *Sinorhizobium meliloti* ([@b14]) and in two plant pathogenic bacteria, *Xylella fastidiosa* ([@b51]) and *Dickeya dadantii* (formerly known as *Erwinia chrysanthemi*) ([@b4]). Herein, we report on the identification of the gene encoding for TolC in *E. amylovora*, the generation and resistance analyses of single and double mutants for *tolC* and *acrB/tolC*, and the determination of virulence and *in planta* survival of the respective mutants.

Results
=======

*In vitro* growth of wild type and mutants of *E. amylovora* Ea1189
-------------------------------------------------------------------

In order to test whether or not individual or combined effects of mutations in *tolC* and *acrB* influenced the overall fitness of respective *E. amylovora* mutants, *in vitro* growth experiments were conducted. Bacteria were cultured in complex Luria--Bertani (LB) and minimal asparagine minimal medium 2 (AMM2) medium at 28°C. The OD~600~ was monitored continuously until cultures had entered the late stationary phase ([Fig. 1](#f1){ref-type="fig"}). Growth of wild‐type cultures was generally faster than that of any mutant tested with doubling times of ∼60 min for the wild type; ∼90 min for the *acrB* mutant; ∼105 min for the *tolC* mutant and ∼120 min for the *acrB/tolC* double mutant. Growth of the genetically complemented mutants was similar to that of the wild type proving that growth delays were directly due to lack of *tolC* and *acrB/tolC*. Wild type and complemented mutants reached the stationary phase within 7 h with an OD~600~ of ∼1.5. In contrast, stationary phases were reached at OD~600~ of ∼1, ∼0.9 and ∼0.8 for the mutants defective in *acrB*, *tolC* and *acrB/tolC* respectively, demonstrating that both, *acrB* and *tolC*, contributed to *in vitro* fitness and that simultaneous mutation of both genes resulted in additive effects. In both media individual growth rates for respective mutants were comparable suggesting that the composition of the growth medium had no effect on particular mutants\' phenotypes.

![*In vitro* growth of *E. amylovora* wild type and mutants in LB (A) and AMM2 (B) medium at 28°C as determined by measurement of the OD~600~. Data represent the means of three independent cultures ± standard deviation.](mbt0002-0465-f1){#f1}

Susceptibility of *tolC* mutants towards phytoalexins and other antimicrobial compounds
---------------------------------------------------------------------------------------

Determination of minimal inhibitory concentrations (MICs) of various antibiotics and phytoalexins was used to examine the susceptibility of *tolC* mutants as compared with the wild‐type strain and the previously studied *acrB* mutant ([@b13]) in complex and minimal medium ([Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}). As potential substrates of TolC and/or AcrAB different isoflavonoids were analysed, which are known phytoalexins in *Rosaceae* plants ([@b24]; [@b21]) and which were previously identified and isolated from apple tissue ([@b59]). Additionally, bile salt as a reported substrate for AcrAB in *E. coli* ([@b58]) and several other antimicrobials were tested in order to determine substrate specificity profiles. In general, differences in MIC values were only considered significant if they were at least fourfold. This cut‐off is consistent with previous publications by others ([@b1001]; [@b3]), due to the sensitivity of the used method, and was meant to avoid misinterpretation of data.

###### 

Susceptibility of *Erwinia amylovora* strains to different compounds in medium MHB.

  Compounds[a](#t1n1){ref-type="table-fn"}   MIC[b](#t1n2){ref-type="table-fn"} (µg ml^−1^)                                     
  ------------------------------------------ ------------------------------------------------ ------- ------- ------- --------- ---------
  Phloretin                                  1000                                             125     125     125     \> 1000   \> 1000
  Naringenin                                 1000                                             62.5    125     125     1000      1000
  (+)‐Catechin                               \> 1000                                          125     250     250     \> 1000   \> 1000
  Quercetin                                  1000                                             62.5    62.5    125     \> 1000   1000
  Berberine                                  1000                                             31.2    31.2    31.2    1000      1000
  Bile salt                                  \> 1000                                          125     125     125     \> 1000   \> 1000
  Acriflavine                                15.6                                             1.56    3.12    3.12    31.2      31.2
  Ampicillin                                 62.5                                             6.25    12.5    6.25    62.5      62.5
  Novobiocin                                 62.5                                             1.56    1.56    1.56    62.5      62.5
  Cefoperazone                               12.5                                             3.12    3.12    3.12    12.5      12.5
  Mitomycin                                  6.25                                             0.31    0.62    0.62    12.5      12.5
  Tetracycline                               6.25                                             0.62    0.62    0.62    12.5      6.25
  Nalidixic acid                             1.25                                             0.12    0.12    0.12    1.25      1.25
  Norfloxacin                                0.62                                             0.031   0.062   0.062   0.62      0.62
  Ciprofloxacin                              0.62                                             0.062   0.062   0.062   0.62      0.62
  SDS                                        \> 1000                                          100     100     100     \> 1000   1000
  Ethidium bromide                           31.2                                             3.12    3.12    3.12    62.5      62.5
  Crystal violet                             3.12                                             0.62    0.62    0.62    3.12      3.12

Reserpine and salicylic acid were also tested (data not shown); however, the mutants and the parent strain showed similar MIC values.

Minimal inhibitory concentration determination by the dilution assay was repeated at least three times in each case thereby confirming consistencies of MIC values.

###### 

Susceptibility of *E. amylovora* strains to different compounds in medium AMM2.

  Compounds[a](#t2n1){ref-type="table-fn"}   MIC[b](#t2n2){ref-type="table-fn"} (µg ml^−1^)                                     
  ------------------------------------------ ------------------------------------------------ ------- ------- ------- --------- ---------
  Phloretin                                  1000                                             31.2    15.6    15.6    \> 1000   \> 1000
  Naringenin                                 1000                                             15.6    31.2    31.2    1000      \> 1000
  (+)‐Catechin                               \> 1000                                          31.2    31.2    31.2    \> 1000   \> 1000
  Quercetin                                  1000                                             31.2    62.5    62.5    \> 1000   \> 1000
  Berberine                                  1000                                             15.6    31.2    31.2    1000      1000
  Bile salt                                  \> 1000                                          31.2    62.5    31.2    \> 1000   \> 1000
  Acriflavine                                15.6                                             3.12    3.12    3.12    31.2      31.2
  Ampicillin                                 31.2                                             1.56    0.75    0.75    31.2      62.5
  Novobiocin                                 125                                              1.56    3.12    3.12    250       250
  Cefoperazone                               6.25                                             1.56    1.56    1.56    12.5      12.5
  Mitomycin                                  12.5                                             0.31    0.31    0.31    12.5      12.5
  Tetracycline                               6.25                                             0.62    0.31    0.62    12.5      6.25
  Nalidixic acid                             2.5                                              0.25    0.25    0.25    2.5       2.5
  Norfloxacin                                0.31                                             0.031   0.062   0.062   0.62      0.62
  Ciprofloxacin                              0.31                                             0.031   0.015   0.015   0.62      0.62
  SDS                                        250                                              3.12    3.12    6.25    250       500
  Ethidium bromide                           62.5                                             3.12    1.56    1.56    62.5      62.5
  Crystal violet                             0.75                                             0.15    0.15    0.31    3.12      1.56

Reserpine and salicylic acid were also tested (data not shown); however, the mutants and the parent strain showed similar MIC values.

Minimal inhibitory concentration determination by the dilution assay was repeated at least three times in each case thereby confirming consistencies of MIC values.

In the *tolC* mutant and the *acrB/tolC* double mutant MICs for the dihydrochalcone phloretin, the flavonol quercetin, the flavanone naringenin, the monomeric flavanol (+)‐catechin, the isoquinoline alkaloid berberine, and bile salt were similar to that of the *acrB* mutant in both media and were decreased 8‐fold, 16‐fold, 16‐fold, 8‐fold, 32‐fold and 8‐fold respectively, as compared with the MICs in the wild type. There were no significant (i.e. more than fourfold) differences between the mutants with single *tolC* knockout or with simultaneous mutations in both, *tolC* and *acrB*, suggesting that both gene products were essential for the efflux of the tested compounds and that neither protein significantly interacted with additional third components to accomplish the efflux.

Complementation of the two single mutants with plasmids pNK7 (for the *tolC* mutant) and pNK8 (for the *acrB* mutant), respectively, fully restored tolerance towards the tested isoflavonoids thereby confirming that these hydrophobic compounds were substrates of the AcrAB--TolC efflux system in *E. amylovora*. The results furthermore suggested that lack of TolC resulted in increased susceptibility possibly due to accumulation of antimicrobials in the bacterial cells.

The three tested mutants were susceptible to the polyketides, tetracycline with a fivefold reduction of MIC values, and to hydrophobic quinolon derivatives such as nalidixic acid, norfloxacin and ciprofloxacin, with a 10‐fold reduction of the MICs. In contrast to the wild type, the mutants were sensitive to the beta‐lactam antibiotics, ampicillin and cefoperazone. In addition, the mutants showed increased susceptibility with about 10‐fold reduction of the MIC to the aminocoumarin novobiocin, the aziridine mitomycin, the antiseptic acriflavine, the detergent SDS, and the dyes, crystal violet and ethidium bromide. Again complementation of either single mutant with the respective genetic locus restored wild‐type resistance levels ([Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}). Only the MICs of reserpine and salicylic acid did not differ from those determined for the wild type (data not shown) suggesting that neither compound acted as a substrate for AcrAB--TolC in *E. amylovora*. Just as observed for the *in vitro* growth, there was no significant (i.e. at least fourfold difference in MIC values) influence of the used growth medium indicating that activity of AcrAB--TolC was not significantly triggered by the physiological state of the cells.

Contribution of TolC to virulence and *in planta* survival of *E. amylovora*
----------------------------------------------------------------------------

First, any potential role for TolC on virulence of the fire blight pathogen was tested by inoculation of apple rootstock MM106 plants with wild type, the *tolC* mutant, and the *acrB/tolC* double mutant. The previously reported *acrB* mutant ([@b13]) was used as a control. Shoot tips of the plants were inoculated by the so‐called prick technique ([@b34]), which mimics the natural infection process and allows for defined numbers of bacterial cells to be inoculated. Observable fire blight symptoms were the typical shepherd\'s crook‐like bending of the shoot tip after 1 week post inoculation as well as ooze formation and necrosis after 3 weeks post inoculation. Such typical symptoms were induced by the wild type of *E. amylovora* Ea1189 ([Fig. 2](#f2){ref-type="fig"}). In contrast to this finding and comparable to the previously published results for the *acrB* mutant of Ea1189, neither the *tolC* mutant nor the *acrB/tolC* double mutant exhibited any disease symptoms ([Fig. 2](#f2){ref-type="fig"}). As expected, genetic complementation rendered the mutants virulent with typical symptoms produced. These result suggested that TolC plays an important role in virulence of the fire blight pathogen. As no significant differences in the lack of symptom developments were observed between the *tolC*, *acrB* and the *acrB/tolC* mutants it could be concluded that both proteins, i.e. TolC and AcrB, were fully required for symptom formation.

![Pathogenicity assay on apple plant. Shoot tips were inoculated with 5 µl of 1 × 10^7^ cfu ml^−1^ bacterial suspensions. Disease symptoms such as the typical 'shepherd\'s crook' formation and wilting developed on plants inoculated with *E. amylovora* wild type after 1 week of inoculation.](mbt0002-0465-f2){#f2}

Next, bacterial colonization of the host plant 24 h post inoculation was studied postulating that TolC and AcrB might be likewise important for this initial step of the disease development. *Erwinia amylovora* Ea1189 and its mutants were inoculated at different cell numbers (10^3^--10^7^ cfu/inoculation sites) and bacterial multiplication was monitored by re‐isolating bacterial cells from infected plant tissue after 24 h ([Table 3](#t3){ref-type="table"}). In contrast to the wild type, inoculation of all three mutants in low cell numbers (10^3^ and 10^4^ cfu/shoot) yielded in no re‐isolatable colony forming units suggesting that the mutants did not survive. Inoculation of the mutants with cell numbers \> 10^5^ cfu/shoot were necessary for re‐isolation of mutant cells. However, the populations decreased approximately 1000‐fold for both single mutants and for the *tolC--acrB* double mutant indicating that mutants with knockout in *tolC* were clearly impaired in multiplication in apple tissue. Noteworthy, mutation of *tolC* in the genomic background of the *acrB* mutant did not lead to any additive effects in terms of this phenotype. In contrast, the wild type reached an approximately 10‐fold increase in population density at 24 h post inoculation regardless of the initially cell numbers used for inoculation (10^3^--10^7^ cfu/shoot). As observed above, complementation of the mutants with plasmids, pNK7 (for the *tolC* mutant) and pNK8 (for the *acrB* mutant), restored the wild‐type phenotype.

###### 

Survival of *E. amylovora* strains in apple rootstock MM106.

  Inoculums[a](#t3n1){ref-type="table-fn"} cfu/shoot   Re‐isolated bacteria cells[b](#t3n2){ref-type="table-fn"} (cfu/shoot)                                                                                                           
  ---------------------------------------------------- ----------------------------------------------------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
  1.2 × 10^3^                                          4.4 × 10^3^ ± 2 × 10^2^                                                 0                         0                         0                         4.1 × 10^3^ ± 2 × 10^2^   4.3 × 10^3^ ± 2 × 10^2^
  1.1 × 10^4^                                          1.6 × 10^5^ ± 2 × 10^3^                                                 0                         0                         0                         1.5 × 10^5^ ± 2 × 10^3^   1.5 × 10^5^ ± 2 × 10^3^
  1.0 × 10^5^                                          5.4 × 10^5^ ± 1 × 10^3^                                                 1.2 × 10^2^ ± 9 × 10^1^   1.5 × 10^2^ ± 6 × 10^1^   1.9 × 10^2^ ± 6 × 10^1^   3.4 × 10^5^ ± 1 × 10^3^   3.4 × 10^5^ ± 1 × 10^3^
  1.2 × 10^6^                                          7.1 × 10^7^ ± 1 × 10^4^                                                 6.4 × 10^3^ ± 2 × 10^2^   8.1 × 10^3^ ± 2 × 10^2^   9.9 × 10^3^ ± 2 × 10^2^   7.6 × 10^7^ ± 1 × 10^4^   7.5 × 10^7^ ± 1 × 10^4^
  1.0 × 10^7^                                          8.8 × 10^8^ ± 2 × 10^5^                                                 1.7 × 10^4 ^± 3 × 10^3^   1.7 × 10^4^ ± 3 × 10^3^   1.8 × 10^4^ ± 3 × 10^3^   8.4 × 10^8^ ± 1 × 10^5^   8.5 × 10^8^ ± 1 × 10^5^

Bacteria were inoculated by prick technique in the shoot tip of plants.

Establishment of a population of *E. amylovora* strains was determined 24 h after inoculation. Data represent the average cfu numbers from 15 individual plants.

Discussion
==========

Herein the role of the outer membrane protein, TolC, for antibiotics resistance, virulence, and *in planta* survival of the fire blight pathogen, *E. amylovora*, was investigated demonstrating its significance for each of these bacterial processes. [@b13]) had previously shown that mutation of *acrB* caused a clear reduction in resistance towards different antibiotics as well as towards plant isoflavonoids, isoprenoids and alkaloids. Furthermore, mutation of *acrB* led to an avirulent phenotype and caused a significant reduction in bacterial *in planta* survival ([@b13]).

The AcrAB--TolC tripartite system of *E. coli* mediates resistance towards a wide variety of lipophilic and amphiphilic compounds including bile salt, detergents, dyes and antimicrobial agents and is one of the best‐characterized bacterial RND‐type MDE pumps ([@b65]). AcrAB--TolC complexes were also described for *Salmonella enterica* ([@b6; @b7]) and *Enterobacter cloacae* ([@b45]). However, in *E. coli*, TolC can also interact with several other transport systems besides AcrAB ([@b54]; [@b50]; [@b27]) prompting the question whether this is also the case for the enterobacterial fire blight pathogen. In Gram‐negative bacteria other than *E. coli*, individual TolC‐like outer membrane channels are often unique for a given RND‐type transporter and their genes are consequently co‐expressed in the same gene cluster as the RND‐type pumps, such as in the case of the *oprJMN* cluster in *Pseudomonas aeruginosa* ([@b31]; [@b26]) or for the outer membrane channel, MtrE, in *Neisseria gonorrhoeae* ([@b22]). In contrast, in *Klebsiella pneumonia* AcrAB homologues specifically interact with the outer membrane protein, KocC, but their respective genes are not co‐transcribed ([@b30]). At least in terms of genomic localization of *acrAB* and *tolC*, *E. amylovora* seems to group along with *E. coli* and some of the other enterobacterial representatives mentioned above. The bicistronic *acrAB* operon (nucleotide numbers 1120951--1125307) is not co‐transcribed with *tolC*, which is located at a very distant position (nucleotide numbers 3269783--3271233) within the *E. amylovora* genome (<http://www.sanger.ac.uk/projects/E.amylovora>).

The initial finding that the *in vitro* growth of the *acrB/tolC* double mutant was more impaired than that of the single mutants seemed to support the idea that AcrAB and TolC of *E. amylovora* may also interact with other proteins. However, simultaneous mutation of *acrB* and *tolC* did not yield in any significant additive or synergistic effects in terms of resistance towards phytoalexins or any other antimicrobial compound suggesting that at least for these functions AcrAB and TolC, respectively, might not recruit other transport partners. For proper *in vitro* growth in both complex and minimal medium, there might be a particular yet‐to‐be identified additional function, which does not require an exclusive AcrAB--TolC interaction.

In comparison with the wild type, the single *tolC* mutant and the *acrB/tolC* double mutant showed significant but similar reductions in resistance towards hydrophobic and amphiphilic antibiotics, dyes and detergents. A wide range of constitutively synthesized isoflavonoids has been described for members of the *Rosaceae* plant family ([@b24]; [@b21]). Notably, [@b35]) found that the glycosides, phloretin, phloridzin and quercetin represented the quantitatively most abundant compounds in apple leaves of the cultivar 'Golden Delicious'. In the current study, the impact of various antibacterial compounds previously described for apple plants ([@b59]) on *E. amylovora* wild type and its mutants were examined. Phloretin, quercetin, (+)‐catechin and naringenin inhibited growth of the *tolC* mutant to very similar extent as the growth of the *acrB/tolC* double mutant and the *acrB* mutant. Consequently, it can be assumed that these compounds are likely to be exported by the AcrAB--TolC complex but not by AcrAB and TolC respectively, recruiting other components in *E. amylovora*. A total of six different MDE systems are present in the genome of *E. amylovora*. A [blast]{.smallcaps} search with the genome sequence of *E. amylovora* Ea237 using the amino acid sequence of AcrB from *E. coli* K12 strain DH10B (accession number YP‐001729367) as query identified six homologous sequences in the genome of Ea237. At the amino acid sequence level, the respective predicted *E. amylovora* proteins showed the following identities (similarities given in brackets): AcrB with 83% (92%), AcrD with 78% (89%), MdtB with 81% (90%), MdtC with 73% (86%), and two MdtB‐ and MdtC‐like proteins with 63% (79%) and 56% (73%) respectively (<http://www.sanger.ac.uk/projects/E.amylovora>).

The increased sensitivity towards diverse antibiotics was comparable to that of the previously described *acrB* mutant of *E. amylovora* and was corresponding to the previously reported broad substrate spectrum of AcrAB--TolC from *E. coli* and other homologous MDE pumps ([@b47]; [@b39]; [@b57]). However, neither of the tested *E. amylovora* mutants showed increased sensitivity towards the indole alkaloid, reserpine, or the plant hormone, salicylic acid, which consequently might not belong to the substrate spectrum of AcrAB--TolC of *E. amylovora*.

In plant‐associated bacteria, TolC was predicted to function in protection against phytoalexins, whose syntheses represent important plant defence mechanisms. For the phytopathogen, *Xylella fastidiosa*, it was shown that a *tolC* knockout impaired virulence and increased sensitivity to the grapevine phytoalexin, resveratrol ([@b51]). Likewise, in the phytopathogen, *Dickeya dadantii* (*E. chrysanthemi*), the importance of *tolC* for virulence and resistance towards plant‐derived chemicals was shown ([@b4]). [@b14]) demonstrated that mutation of *tolC* in the nitrogen‐fixing plant symbiont, *Sinorhizobium meliloti*, strongly affected the resistance against antimicrobial agents and was important for symbiotic functions. Herein, we demonstrated that individual or simultaneous disruption of single components of a MDE pump in *E. amylovora* resulted in similarly reduced symptom formation and in significantly reduced *in planta* survival shortly after infection. These findings indicated that the detoxifying activity might be linked to AcrAB--TolC as a complex. Thus, the infected plants were obviously able to block the infection and kill bacterial cells if those lacked the gene products of *acrB* or *tolC*. The results were substantiated by genetic complementation of the mutants to wild‐type levels with recombinant *acrAB* and *tolC*. It is tempting to speculate that the AcrAB--TolC complex might enable bacterial cells to survive at and outgrow from the local infection site, in which antimicrobial substances of plant defence accumulate during early stages of infection.

*Erwinia amylovora* wild type and its mutants were additionally inoculated on tobacco leaves to monitor the development of the hypersensitive response (data not shown). Regardless of their reduced virulence, the *acrB* and *tolC* mutants elicited typical hypersensitive responses during the incompatible reaction with tobacco plants demonstrating that the *hrp* type III secretion system ([@b40]) was not influenced by the MDE system. For *E. chrysanthemi*, the TolC analogue, PrtF, was shown to be required for the secretion of a protease important for virulence ([@b32]). Our future studies will therefore focus on the in‐depth analysis of potential function(s) of TolC in protein secretion as well as on the genetic exchange of individual AcrAB--TolC components between *E. amylovora* and *E. coli* in order to determine ecological niche‐mediated specializations of either system. Additionally, future work will be directed towards the transcriptional regulation of the *tolC* gene of *E. amylovora* in order to determine whether its expression is substrate‐dependent and whether expression of *acrAB* ([@b13]) and that of *tolC* is co‐regulated by any potential substrate(s).

Experimental procedures
=======================

Bacterial strains, plasmids and growth conditions
-------------------------------------------------

Bacterial strains and plasmids used in this study were listed in [Tables 4](#t4){ref-type="table"} and [5](#t5){ref-type="table"}. *Erwinia amylovora* strains were cultured at 28°C on LB medium or AMM2. Asparagine minimal medium 2 has the following composition (per litre of deionized water): fructose, 10 g; [l]{.smallcaps}‐asparagine, 4 g; Na~2~HPO~4~ × 7 H~2~O, 12.8 g; K~2~HPO~4~, 3 g; NaCl, 3 g; MgSO~4~ × 7 H~2~O, 0.2 g; nicotinic acid, 0.25 g; thiamine, 200 µg. *Escherichia coli* DH5α was used as cloning host. *Escherichia coli* cells were routinely maintained at 37°C in LB medium. Cultures were supplemented with 50 µg ml^−1^ ampicillin (Ap), 25 µg ml^−1^ chloramphenicol (Cm), gentamicin (Gm) at 2 µg ml^−1^ and 25 µg ml^−1^ kanamycin (Km) when necessary. Bacterial growth was monitored using a spectrophotometer (OD at 600 nm).

###### 

*E. coli* and *E. amylovora* strains used in this study.

  Strain           Relevant characteristics                                                                                            Reverence or source
  ---------------- ------------------------------------------------------------------------------------------------------------------- -------------------------------------
  *E. coli*                                                                                                                            
   DH5α            *supE*44 Δ*lac*U169 (φ80 *lacZ*ΔM15) *hsdR*17 *recA*1 *endA*1 *gyrA*96 *thi‐*1 *relA*1                              [@b52])
   S17‐1 *λ‐pir*   *λ‐pir* lysogen of S17‐1                                                                                            [@b64])
  *E. amylovora*                                                                                                                       
   1189            Wild type                                                                                                           GSPB[a](#t4n1){ref-type="table-fn"}
   1189‐3          Km^r^, *acrB* mutant carrying Km^r^ cassette in the *acrB* gene                                                     [@b13])
   1189‐25         Gm^r^, *tolC* mutant carrying GFP‐Gm^r^ cassette in the *tolC* gene                                                 This study
   1189‐3‐3        Km^r^, Gm^r^, *acrB/tolC* mutant carrying GFP‐Gm^r^ cassette in the *tolC* gene and Km^r^ cassette in *acrB* gene   This study
   1189‐25‐1       Gm^r^, Cm^r^, complemented *tolC* mutant carrying pNK7                                                              This study
   1189‐3‐1        Km^r^, Cm^r^, complemented *acrB* mutant carrying pNK8                                                              This study

GSPB, Göttinger Sammlung phytopathogener Bakterien, Göttingen, Germany.

###### 

Plasmids used in this study.

  Plasmid       Relevant characteristics                                                                                                                   Reference or source
  ------------- ------------------------------------------------------------------------------------------------------------------------------------------ ---------------------
  pGEM‐T Easy   Ap^r^, ColE1 origin                                                                                                                        Promega
  pNK1          Ap^r^, contains a 984 bp XhoI PCR fragment that located upstream of *tolC*.                                                                This study
  pNK2          Ap^r^, contains a 912 bp XhoI/BamHI PCR fragment located downstream of *tolC*                                                              This study
  pPS858        Source of the Gm‐GFP cassette                                                                                                              [@b25])
  pNK3          Ap^r^, Gm^r^, 1843 bp Gm‐GFP cassette from pPS858 cloned into BamHI‐linearized pNK2                                                        This study
  pNK4          Ap^r^, Gm^r^, 2755 bp SpeI‐XhoI GFPGm‐downstream fragment from pNK3 cloned into SpeI‐XhoI‐linearized pNK1                                  This study
  pCAM‐MCS      Ap^r^, pCAM140‐derivative without mini‐Tn5, contains the MCS of pBluescript II SK (+)                                                      [@b13])
  pNK5          Ap^r^, Gm^r^, 3739 bp ScaI‐EcoRI upstream‐GFPGm‐downstream fragment cloned into EcoRI‐linearized pCAM‐MCS                                  This study
  pNK6          Ap^r^, contains a 2630 bp PCR fragment carrying the *tolC* gene, upstream and downstream of the gene                                       This study
  pNK7          Cm^r^, contains a 2.6 kb fragment carrying *tolC* of *E. amylovora* cloned in pBBR1MCS by SpeI and SacII in opposite direction of *lacZ*   This study
  pNK8          Cm^r^, contains a 4.9 kb fragment carrying *acrAB* of *E. amylovora* cloned in pBBR1MCS by SpeI and SacI in opposite direction of *lacZ*   This study

Ap, ampicillin; Gm, gentamicin; Km, kanamycin; Cm, chloramphenicol; GFP, green fluorescent protein.

Standard genetic procedures
---------------------------

Restriction digestions, agarose gel electrophoresis, electroporation, PCR, ligation of DNA fragments, plasmid DNA isolation, and other routine molecular methods were performed by standard techniques ([@b52]). Purification of PCR products and DNA fragments from agarose gels were performed using Nucleospin columns (Macherey‐Nagel, Dueren, Germany).

Generation of *tolC* in *E. amylovora*
--------------------------------------

*Erwinia amylovora tolC*‐deficient mutants were generated by marker exchange mutagenesis as follows. Two fragments flanking the *tolC* gene were PCR‐amplified from strain Ea1189 using the oligonucleotide primer pairs Ea‐tolC‐FwdI, Ea‐tolC‐RevI and Ea‐tolC‐FwdII, Ea‐tolC‐RevII respectively ([Table 6](#t6){ref-type="table"}). PCR products were cloned into pGEM‐T Easy (Promega, Mannheim, Germany) yielding plasmids pNK1 (3999 bp) and pNK2 (3927 bp). A 1843 bp BamHI fragment containing a green fluorescent protein--gentamicin‐resistance cassette (GFP‐Gm^r^) was derived from pPS858 ([@b25]) and ligated into BamHI‐digested pNK2, yielding the 5767 bp plasmid pNK3. A 984 bp XhoI‐SpeI fragment was derived from pNK1 and ligated into XhoI‐SpeI‐digested pNK3, yielding the 6751 bp plasmid pNK4. A 3739 bp EcoRI fragment was obtained from pNK4 and ligated into EcoRI‐digested suicide plasmid, pCAM‐MCS ([@b13]), yielding the final *tolC* replacement plasmid pNK5 (7439 bp). *Escherichia coli* S17‐1 *λ‐pir* was used as host for the suicide plasmid. The plasmid was transferred via electroporation to electro‐competent *E. amylovora* wild type and its *acrB* mutant, which subsequently were grown at 28°C for 1 h in SOC broth and plated on LB containing gentamicin. Putative mutants were screened for homologous recombination events by checking for antibiotics resistance and GFP fluorescence. To confirm the altered genotypes, PCR amplification of *tolC* using primers Ea‐tolC‐FwdI and Ea‐tolC‐RevII ([Table 6](#t6){ref-type="table"}) was carried out, yielding a 3739 bp fragment for the two mutants, as opposed to the presence of wild‐type *tolC*, forming a 2630 bp PCR fragment in samples of wild type and *acrB* mutant.

###### 

Oligonucleotide primers used in this study.

  Primer           Nucleotide sequence (5′‐3′)[a](#t5n1){ref-type="table-fn"}
  ---------------- ------------------------------------------------------------
  Ea‐tolC‐FwdI     GCTCACCACATGCACAAG
  Ea‐tolC‐RevI     CTCGAGAGTGTTGCTGTTAGAGCCAC
  Ea‐tolC‐FwdII    GCCAAATTCAGCCACGCA
  Ea‐tolC‐RevII    CTCGAGGATCCGCAAGTGAACAGCTCGAAG
  Ea‐acr‐Com‐Fwd   CGAGAGCTCCGCCAGTGACGTATTAGC
  Ea‐acr‐Com‐Rev   GATACTAGTCGGTATAGTAAACGTGCG

Restriction sites incorporated into primers are underlined: CTCGAG, XhoI; GGATCC, BamHI; GAGCTC, SacI; ACTAGT, SpeI.

Complementation of mutants
--------------------------

Genetic complementation of *tolC* mutants was performed as follows: a 2630 bp fragment including the *tolC* gene and its upstream and downstream regions was PCR‐amplified from strain Ea1189 using the oligonucleotide primers, Ea‐tolC‐FwdI and Ea‐tolC‐RevII ([Table 6](#t6){ref-type="table"}), cloned into pGEM‐T Easy yielding the 5645 bp plasmid pNK6. A 2630 bp SpeI‐SacII fragment was derived from pNK6 and ligated into SpeI‐SacII‐digested pBBR1MCS ([@b28]) yielding the final *tolC* complementation plasmid pNK7 (7337 bp). Complementation of the *acrB* mutant was performed as follows: a 4917 bp fragment including *acrAB* and its upstream and downstream region was PCR‐amplified from Ea1189 using the oligonucleotide primers, Ea‐acr‐Com‐Fwd and Ea‐acr‐Com‐Rev ([Table 6](#t6){ref-type="table"}), cloned into SpeI‐SacI‐digested pBBR1MCS ([@b28]) yielding the final *acrAB* complementation plasmid pNK8 (9624 bp). Plasmids pNK7 and pNK8 were transferred to electro‐competent cells of the *E. amylovora tolC* and *acrB* mutants respectively, which subsequently were grown at 28°C for 1 h in SOC broth and plated on LB containing appropriate antibiotics. To confirm complementation of the genotypes, plasmids were re‐isolated from the complemented cells and the target gene(s) were PCR‐amplified using appropriate oligonucleotides.

Drug susceptibility tests
-------------------------

The MICs of diverse antibiotics were determined by a dilution assay in Mueller--Hinton broth (MHB) (Becton Dickinson, Heidelberg, Germany) and AMM2 respectively. All tests were done in triplicate following the [@b38]) recommendations. Briefly, testing of MIC was carried out in micro‐titer plates with 96 flat‐bottomed wells. With the exception of those wells used as control, each well received 100 µl of a twofold dilution series of an antibiotic solution in the appropriate medium. Than each well except those used as sterility controls received 100 µl of bacterial suspension at 1 × 10^6^ cfu ml^−1^. The MIC was defined as the lowest concentration of an antibiotic that completely stopped visible cell growth. Growth of *E. amylovora* at 28°C was examined by visual and photometric inspection after 24 h of incubation.

Plant materials and pathogenicity assay on apple plants
-------------------------------------------------------

Apple plants (rootstock *Malus* MM106) were grown in a light chamber at 20--25°C, 60% humidity, with a 12 h photoperiod (15 000 lux). *Erwinia amylovora* strains were grown on LB agar plates for 48 h, resuspended in sterile 0.9% NaCl solution and diluted to a cell density of 1 × 10^7^ cfu ml^−1^ for inoculation. Apple plants were inoculated by the prick technique as described by [@b34]). Each bacterial strain was inoculated into shoots of five individual plants by placing 5 µl of bacterial suspensions onto each wound on the shoot tip. Plants were monitored for symptom development daily.

To study bacterial survival in plant tissue, 5 µl of bacterial suspensions (10^2^--10^6^ cfu ml^−1^) was placed onto each wound on the shoot tips of nine individual plants. Sterile 0.9% NaCl solution was used as negative controls. Survival of bacteria in the plant tissue was examined by re‐isolation of bacterial cells 24 h post inoculation. One centimetre of the shoot tip around the inoculation site was cut off. Samples from apple plants were pooled, homogenized in 0.9% NaCl solution, serially diluted, and appropriate dilutions were spread on LB agar plates.

All greenhouse experiments were repeated at least three times to confirm reproducibility and to calculate standard deviations.

Nucleotide sequence accession number
------------------------------------

The nucleotide sequence of the *tolC* gene of *E. amylovora* 1189 was deposited in GenBank under Accession No. FJ462442.
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